Evidence map›Paper›PMID 34842694›Full record

ArticleGels (Basel, Switzerland)2021

Functionalized Poly(

Simona Campora, Reham Mohsen, Daniel Passaro, Howida Samir, Hesham Ashraf, Saif El-Din Al-Mofty, Ayman A Diab, Ibrahim M El-Sherbiny, Martin J Snowden, Giulio Ghersi

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Phase Transition Behaviors of Poly(Molecules (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Simona CamporaDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 16, 90128 Palermo, Italy.ORCID 0000-0003-3786-6812
Reham MohsenFaculty of Biotechnology, October University for Modern Sciences and Arts, Cairo 12451, Egypt.
Daniel PassaroDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 16, 90128 Palermo, Italy.
Howida SamirFaculty of Biotechnology, October University for Modern Sciences and Arts, Cairo 12451, Egypt.
Hesham AshrafFaculty of Biotechnology, October University for Modern Sciences and Arts, Cairo 12451, Egypt.ORCID 0000-0002-5317-8254
Saif El-Din Al-MoftyCenter of Materials Science, Zewail City of Science and Technology, 6th October City, Giza 12588, Egypt.ORCID 0000-0001-7708-7413
Ayman A DiabFaculty of Biotechnology, October University for Modern Sciences and Arts, Cairo 12451, Egypt.
Ibrahim M El-SherbinyCenter of Materials Science, Zewail City of Science and Technology, 6th October City, Giza 12588, Egypt.ORCID 0000-0002-8179-437X
Martin J SnowdenSchool of Science, University of Greenwich, Gillingham, Chatham, Kent, Canterbury ME4 4TB, UK.
Giulio GhersiDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 16, 90128 Palermo, Italy.ORCID 0000-0001-7250-9808
October University of Modern Sciences and Arts · EGUniversity of Palermo · ITUniversity of Greenwich · GBZewail City of Science and Technology · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past several decades, the development of engineered small particles as targeted and drug delivery systems (TDDS) has received great attention thanks to the possibility to overcome the limitations of classical cancer chemotherapy, including targeting incapability, nonspecific action and, consequently, systemic toxicity. Thus, this research aims at using a novel design of Poly(

Indexed as

cancerdoxorubicinfolic acidp(NIPAM)-co-5%AA microgels

Identifiers

PMID34842694
PMCPMC8628686
OpenAlexW3212826319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.